Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial
Publication year
1996Source
Bone Marrow Transplantation, IV, (1996), pp. 993-1001ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Haematology
Journal title
Bone Marrow Transplantation
Volume
vol. IV
Page start
p. 993
Page end
p. 1001
Subject
European evaluation of intensive antileukemic therapy for patients with myelodysplastic syndrome (MDS) CRIANT: clonal remission after intensive antileukemic therapy (Biomed-2 1995)This item appears in the following Collection(s)
- Academic publications [202563]
- Faculty of Medical Sciences [79925]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.